MedTrace Logo

Cholesterol Homeostasis in Framingham Offspring Study

NCT00074464 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3378

Last updated 2013-05-06

No results posted yet for this study

Summary

To investigate the predictive value of using measures of cholesterol homeostasis to identify individuals at high risk of developing cardiovascular disease relative to established risk factors.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Tufts University

    lead OTHER

Principal Investigators

  • Alice Lichtenstein · Tufts University

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-08-31
Primary Completion
2008-07-31
Completion
2008-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00074464 on ClinicalTrials.gov